Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

Citi reaffirmed a positive stance on Talos Energy (NYSE:TALO) shares, maintaining a Buy rating and a $14.50 price target. The endorsement comes following the company's announcement on Monday regarding ...

In a tale of heartbreak that has bewildered the internet, New Yorker Onijah Andrew Robinson, 32, has become a social media ...

The outcome of the 2024 U.S. election had far-reaching implications for the global investment landscape, especially in the dynamic field of ...

Meeting Tuesday morning at the J.P. Morgan Healthcare Conference this year, women leaders in life sciences, women’s health, and entrepreneurship ...

Another year at the J.P. Morgan Healthcare Conference is in the books. | While major payers skipped out on this year’s event, ...

National leaders in health, technology, education, and policy gathered Friday, Jan. 10, at the Crystal Bridges Museum of ...

What does Trump's decision to leave the WHO mean for public health? And should U.S. companies be intimidated by Chinese drug ...

Under his leadership, the bureau has tackled junk fees, limited overdraft penalties and removed medical debt from people’s ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

It’s unclear which conference the lawsuit is referring to, but JPMorgan Chase’s annual health care conference, held at the Westin St. Francis hotel near Union Square this week and featuring ancillary ...